PEN:NYSE
Penumbra Inc
US$ ३१७.५५
arrow_downward
-०.१४%(-०.४५) 1D
US$ ३१७.५४
arrow_downward
-०.००% (-०.००७९)bedtimeAfter hours
Closed: अक्टोबर २, १६:००:०४ GMT-४ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PEN...
Open
US$ ३१८.३७
High
US$ ३१८.३७
Low
US$ ३१६.७८
Mkt. cap
१२.५१ अरब
Avg. vol.
३.५२ लाख
Volume
२.४० लाख
P/E ratio
७७.९९
52-wk high
US$ ३६२.४१
52-wk low
US$ २२१.२६
EPS
US$ ४.०७
Beta
०.७०
Shares outstanding
३.९४ करोड
No. of employees
५ हजार
Open
US$ ३१८.३७
High
US$ ३१८.३७
Low
US$ ३१६.७८
Mkt. cap
१२.५१ अरब
Avg. vol.
३.५२ लाख
Volume
२.४० लाख
P/E ratio
७७.९९
52-wk high
US$ ३६२.४१
52-wk low
US$ २२१.२६
EPS
US$ ४.०७
Beta
०.७०
Shares outstanding
३.९४ करोड
No. of employees
५ हजार
News stories
From web sources and news partners
Simply Wall Street
·
४९ मिनेट पहिले
What Had To Hold Up For OptimizeRx (OPRX) And What Broke First?
TradingKey
·
२० मिनेट पहिले
S&P 500 vs. Nasdaq 100: Which Is Better for Long-Term Investment?
Business Insider
·
१६ घण्टा पहिले
The NYSE's Most Famous Floor Trader Says AI Can't Take His Job
The Motley Fool
·
४ घण्टा पहिले
History Says Coca-Cola Stock Holds Up When the S&P 500 Falls
Profile
Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm.
In January 2026, Boston Scientific announced it would acquire Penumbra in a $15 billion cash and stock deal. The deal was expected to close by year-end. Wikipedia
About Penumbra Inc